Introduction
Pleurodesis defined as symphysis between two layers of pleura to prevent recurrence of effusion. Chemical pleurodesis is the best available treatment for recurrent effusions of incurable malignancies. An ideal agent must be highly effective, easy to administer, safe, inexpensive, and readily available. Such an ideal agent is yet to be identified, and choice depends on the local availability and experience. Povidone-iodine is a topical antiseptic and has been shown to be safe and effective in several series [1] [2] [3] [4] [5] including one multicenter study [3] and in two small series. [5, 6] Povidone-iodine was selected over the other agents due to its cost-effectiveness and fewer side effects. This study aims to assess the safety and efficacy of povidone-iodine for pleurodesis.
Materials and Methods
This study was done to evaluate the efficacy of the pleurodesis procedure with povidone-iodine. One hundred and four cases of malignant pleural effusion that underwent pleurodesis with povidone-iodine for symptomatic effusion at our center from the period of June 2008 to August 2015 were analyzed. The British Thoracic Society guidelines were followed for managing malignant pleural effusion and for pleurodesis. [7] Chest tube (28F) was inserted through the midaxillary line in the fifth intercostal space to achieve complete drainage of the effusion and lung re-expansion. Re-expansion was verified radiographically. As soon as the effusion was completely drained and the lung fully expanded, pleurodesis was performed. Pleurodesis was done after a mean duration of 11.72 days (range 3-36 days) after the placement of intercostal drain. Lidocaine (4 mg/kg) diluted with normal saline to a volume of 50 ml was infused through the chest tube. Implanted cardioverter defibrillator (ICD) was clamped for 15 min, and patient was advised to change position for distribution of anesthetic agent uniformly. After 15 min, a pleurodesis solution containing a mixture of 20 ml 10% povidone-iodine and 80 ml normal saline solution was infused into the pleural cavity, after which the tube was clamped for 2 h, and patient This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms.
For reprints contact: reprints@medknow.com agent should have a high molecular weight and chemical polarity, low regional clearance, rapid systemic clearance, and a steep dose-response curve and should be well tolerated with minimal or no side effects. [7] The choice of a sclerosing agent is not only determined by the efficacy of the agent but also by its cost, accessibility, safety, ease of administration, and the number of administrations required to achieve a complete response.
Although talc is effective, there is an increasing concern about its safety. [8, 9] In a study by Walker-Renard et al., [10] talc has been the most effective chemical agent for malignant pleural effusions, with a complete success rate of 93% in 1168 patients, compared with Corynebacterium parvum (76%), tetracycline (67%), doxycycline (72%), and bleomycin (54%).
The efficacy of povidone-iodine has been previously described. In a study by Echavarría et al., [1] pleurodesis with povidone-iodine was performed in 15 patients with malignant pleural effusions and achieved control of the effusion in all the patients. In another study by Kelly-Garcia et al., [5] success was achieved in 9 of 14 patients (64.2%) in whom povidone-iodine pleurodesis was performed.
Povidone-iodine is iodine-based topical antiseptic. The mechanism of action of povidone-iodine appears to be related to enhanced sclerosis although the precise mode of action remains unclear. It may be related to the low pH (2.97) of the sclerosing solution. [4] Furthermore, iodine has strong oxidative and cytotoxic properties, which can induce a potent inflammatory response in the wall of any fluid-containing structure. Moreover, povidone-iodine may have anti-exudative properties related to the chelation of proteins. [6] Theoretically, the mechanism could also be similar to that described for talc, namely, the production of fibroblast growth factor. [8] Although povidone-iodine does cause chest pain, intensity described in different studies varies as procedural sedation has been used in most studies. Another side effect reported was the occurrence of hypotension in three patients with mesothelioma. [6] However, it was not clear whether the hypotension was an anaphylactic reaction or a pain-associated vasovagal reaction. However, iodine can cause severe allergic reactions, especially in patients with an allergic diathesis, and one should be prepared to deal with this emergency.
Conclusion
The efficacy of povidone-iodine is comparable to that of talc but without the risk of severe complications such as acute respiratory distress syndrome. Pleurodesis with povidone-iodine can be performed under local anesthesia with excellent tolerance. In conclusion, povidone-iodine is an effective, safe, readily available, and inexpensive agent for chemical pleurodesis in cases of recurrent, incapacitating effusions.
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There are no conflicts of interest. internal echoes, and debris within it was observed that mimicked long-standing hydronephrosis accompanied pyonephrosis.
A double phase contrast enhanced multidetector computed tomography (CT) of the abdomen was performed on 64 slice Somatom sensation machine from Siemens Company with an oral and intravenous injection of 100 ml nonionic contrast medium. The CT examination includes plain, arterial, venous, and delayed phase. The study reveals multicystic mass in the right lumbar region involving entire kidney. Radical nephrectomy was performed.
Grossly right kidney was completely replaced by lobulated multicystic mass measuring 17 cm × 13 cm × 7 cm, filled with pus and a large amount of mucin.
Histopathology revealed that tumor show a malignant tumor comprising of cells arranged in papillary fronds. Individual cells are large, columnar having fine granular basophilic/clear cytoplasm with well-depicted borders and round vesicular nuclei with mild anisonucleosis. Some cells show prominent
